SCHEMBL4638604

SCHEMBL4638604

COC(=O)CC(c1ccc(OC)c(OC2CCC3CCC2C3)c1)N1C(=O)c2ccccc2C1=O

nearest known ligand 0.90

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 9/20 0.90
PDE4B Q07343 9/20 0.90
PDE4C Q08493 9/20 0.90
PDE4D Q08499 9/20 0.90
TNF P01375 13/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4637168 0.95 PDE4A (1.00) PDE4APDE4BPDE4CPDE4DTNF
SCHEMBL4638557 0.94 PDE4A (0.92) PDE4APDE4BPDE4CPDE4DTNF
SCHEMBL4637166 0.92 PDE4A (0.77) PDE4APDE4BPDE4CPDE4DTNF
SCHEMBL4637192 0.92 PDE4A (0.77) PDE4APDE4BPDE4CPDE4DTNF
SCHEMBL4637162 0.87 PDE4B (0.85) PDE4APDE4BPDE4CPDE4DTNF
SCHEMBL4637285 0.87 PDE4A (0.85) PDE4APDE4BPDE4CPDE4DTNF
SCHEMBL4637229 0.86 PDE4A (0.78) PDE4APDE4BPDE4CPDE4DTNF
SCHEMBL5905773 0.83 PDE4A (0.72) PDE4APDE4BPDE4CPDE4DTNF
SCHEMBL4637242 0.83 PDE4A (1.00) PDE4APDE4BPDE4CPDE4DTNF
SCHEMBL6691621 0.83 TNF (1.00) PDE4APDE4BPDE4CPDE4DTNF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1468991-B1 Imides as PDE III, PDE IV and TNF inhibitors CELGENE CORP (US) 2008-02-20 EP disclosed
EP-1468991-A1 Imides as PDE III, PDE IV and TNF inhibitors CELGENE CORPORATION (US) 2004-10-20 EP disclosed
EP-0874819-B1 IMIDES AS PDE III, PDE IV AND TNF INHIBITORS CELGENE CORP (US) 2004-05-26 EP disclosed
EP-0874819-A1 IMIDES AS PDE III, PDE IV AND TNF INHIBITORS CELGENE CORPORATION (US) 1998-11-04 EP disclosed
WO-1997023457-A1 IMIDES AS PDE III, PDE IV AND TNF INHIBITORS CELGENE CORPORATION (US) 1997-07-03 WO disclosed